ROSEN, TRUSTED INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – ICPTBusiness Wire • 12/05/20
Notice of Lead Plaintiff Deadline for Shareholders in the Intercept Pharmaceuticals, Inc. Class Action LawsuitBusiness Wire • 12/03/20
ROSEN, A TOP RANKED LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm - ICPTNewsfile Corp • 12/02/20
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Intercept Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – ICPTGlobeNewsWire • 12/01/20
ROSEN, GLOBAL INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPTGlobeNewsWire • 11/26/20
ROSEN, A LEADING LAW FIRM, Reminds Intercept Pharmaceuticals, Inc. Investors of Important January 4 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm - ICPTPRNewsWire • 11/25/20
Intercept to Present at the Piper Sandler 32nd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/24/20
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Reminds Intercept Pharmaceuticals, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact Firm – ICPTBusiness Wire • 11/20/20
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Intercept Pharmaceuticals, Inc. (ICPT) InvestorsPRNewsWire • 11/18/20
ROSEN, A TOP RANKED LAW FIRM, Announces Filing of Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - ICPTNewsfile Corp • 11/17/20
ICPT Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Intercept Pharmaceuticals, Inc. Shareholders of Class Action and Lead Plaintiff Deadline: January 4, 2021Business Wire • 11/17/20
New Data from the Interim Analysis of REGENERATE Show OCA Improved Noninvasive Measures of Fibrosis in a Subgroup of High-Risk Patients with Fibrosis Due to NASHGlobeNewsWire • 11/16/20
ROSEN, RESPECTED INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Intercept Pharmaceuticals, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm - ICPTPRNewsWire • 11/14/20
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Intercept Pharmaceuticals, Inc. (ICPT)Business Wire • 11/13/20
Scott+Scott Attorneys at Law LLP Reminds Investors of Securities Class Action Against Intercept Pharmaceuticals, Inc. (ICPT) and January 4 Lead Plaintiff DeadlineBusiness Wire • 11/13/20
The Brualdi Law Firm, P.C. Announces Class Action Lawsuit against Intercept Pharmaceuticals, Inc.Newsfile Corp • 11/13/20
DEADLINE FOR ICPT INVESTORS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Filed Against Intercept Pharmaceuticals, Inc.Newsfile Corp • 11/12/20
Intercept Pharmaceuticals, Inc. (ICPT) CEO Mark Pruzanski on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/09/20
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Intercept Pharmaceuticals, Inc. (ICPT) InvestorsBusiness Wire • 11/06/20
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Intercept Pharmaceuticals, Inc. (ICPT) InvestorsBusiness Wire • 11/06/20
INTERCEPT PHARMACEUTICALS ALERT: Bragar Eagel & Squire, P.C. is Investigating Intercept Pharmaceuticals, Inc. on Behalf of Intercept Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 11/03/20
Intercept to Announce Third Quarter 2020 Financial Results on November 9, 2020GlobeNewsWire • 11/02/20
